Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 27;13(15):2511.
doi: 10.3390/diagnostics13152511.

Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson's Disease in the First 6 Years of Levodopa Treatment

Affiliations

Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson's Disease in the First 6 Years of Levodopa Treatment

Yang Luo et al. Diagnostics (Basel). .

Abstract

Background: Current research on the prediction of movement complications associated with levodopa therapy in Parkinson's disease (PD) is limited. levodopa-induced dyskinesia (LID) is a movement complication that seriously affects the life quality of PD patients. One-third of PD patients develop LID within 1 to 6 years of levodopa treatment. This study aimed to construct models based on radiomics and machine learning to predict early LID in PD.

Methods: We extracted radiomics features from the T1-weighted MRI obtained in the baseline of 49 PD control and 54 PD with LID in the first 6 years of levodopa therapy. Six brain regions related to the onset of PD were segmented as regions of interest (ROIs). The least absolute shrinkage and selection operator (LASSO) was used for feature selection. Using the machine learning methods of support vector machine (SVM), random forest (RF), and AdaBoost, we constructed radiomics models and hybrid models. The hybrid models combined the radiomics features and the Unified Parkinson's Disease Rating Scale part III (UPDRS III) total score. The five-fold cross-validation was performed and repeated 20 times to validate the stability of the classifiers. We used sensitivity, specificity, accuracy, receiver operating characteristic (ROC) curves, and area under the ROC curve (AUC) for model validation.

Results: We selected 33 out of 6138 radiomics features. In the testing set of the radiomics model, the AUC values of the SVM, RF, and AdaBoost classifiers were 0.905, 0.808, and 0.778, respectively, and the accuracies were 0.839, 0.742, and 0.710. The hybrid models had better prediction performance. In the testing set, the AUC values of SVM, RF, and AdaBoost classifiers were 0.958, 0.861, and 0.832, respectively, and the accuracies were 0.903, 0.806, and 0.774.

Conclusions: Our results indicate that T1-weighted MRI is valuable in predicting early LID in PD. This work demonstrates that the combination of radiomics features and clinical features has good potential and value for identifying early LID in PD.

Keywords: Parkinson’s disease; dyskinesias; levodopa; machine learning; magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the current research.
Figure 2
Figure 2
Pipeline for image preprocessing: (a) original T1-weighted MRI of individual patient; (b) T1 image after cranium removal; (c) Montreal Neurosciences Institute 152 (MNI152) standard space; (d) normalized T1 image; (e) automated anatomical labeling atlas 3; (f) the regions of interest segmented from the atlas; (g) the regions of interest segmented from the individual normalized image. FSL, the FMRIB Software Library; ANTs, Advanced Normalization Tools.
Figure 3
Figure 3
The process and main methods of constructing the radiomic models. There were three steps after image preprocessing: (1) feature extraction; (2) feature selection; (3) classifier construction. (a) The normalized T1 image and the masks of ROIs; (b) the types of radiomics features; (c) LASSO regression and variable filtering; (d) the correlation coefficient heatmap of selected features; (e) the ROC curve of hybrid models.
Figure 4
Figure 4
The ROC curves of the radiomics models and hybrid models in the testing set.

References

    1. Tysnes O.B., Storstein A. Epidemiology of Parkinson’s disease. J. Neural Transm. 2017;124:901–905. doi: 10.1007/s00702-017-1686-y. - DOI - PubMed
    1. Tolosa E., Garrido A., Scholz S.W., Poewe W. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021;20:385–397. doi: 10.1016/S1474-4422(21)00030-2. - DOI - PMC - PubMed
    1. Bloem B.R., Okun M.S., Klein C. Parkinson’s disease. Lancet. 2021;397:2284–2303. doi: 10.1016/S0140-6736(21)00218-X. - DOI - PubMed
    1. Beitz J.M. Parkinson’s disease: A review. Front. Biosci. (Schol. Ed.) 2014;6:65–74. doi: 10.2741/S415. - DOI - PubMed
    1. Armstrong M.J., Okun M.S. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323:548–560. doi: 10.1001/jama.2019.22360. - DOI - PubMed

LinkOut - more resources